Biotech Industry Partners

Our goal is to develop and provide innovative diagnostic tools to improve physician’s capabilities through our state-of-the-art testing laboratory.

Intermountain Precision Genomics® is transforming healthcare by targeting treatment to deliver the highest quality care at some of the lowest costs in the nation, all while helping people live the healthiest lives possible®. Using state-of-the-art technologies, Intermountain Precision Genomics® can get right down to your DNA to personalize care to you.

GeneSTAT Molecular Diagnostics, LLC (GMD) develops and manufactures high value molecular diagnostic instruments/platforms and tests with an emphasis in the area of infectious diseases. The company’s primary focus is on bringing the benefits of molecular testing to emerging diseases and unique applications, so that diagnostic information is more readily and quickly available.

Soft Cell Biological Research (BSCR) Investigate the circulating microbiome comprised of the persister, resister, dormant and L-form bacteria. Uniquely, we can culture & sequence the bacteria and understand their role in chronic disease.

As a large-scale producer of hemp-derived CBD and other cannabinoids operating under ISO 9001:2015 and cGMP adherence, we specialize in serving the supply chain needs of end product formulators. We relentlessly pursue being your dependable source, helping avoid supply chain disruptions, while creating efficiencies with fewer CoAs and reformulations inherent with multiple sources or small batch processing.

As an industry leader in full-service custom manufacturing, Deseret Laboratories, Inc. has become known around the world for its integrity, solution-minded capabilities and its state-of-the-art facilities. DLI’s team of dedicated professionals work closely with its Nutraceutical, Pharmaceutical, Over-the-Counter and Homeopathic customers to ensure them the delivery of on-time quality, and value in every product.

Culmination Bio is an Intermountain Healthcare company. We collaborate with commercial partners, including leading technology and biopharmaceutical companies, to provide novel clinical insights, therapeutic targets, diagnostic opportunities, and care process models. Our exclusive Culmination intelligence database is informed by diverse, multi-dimensional, longitudinal clinical data and matched biospecimens. The ability to provide or produce omics-level data makes the Culmination intelligence platform an extraordinarily powerful insights engine for medical research, health data, and healthcare services.

Our mission is to discover a safe and effective treatment that will prevent and halt progression of Alzheimer’s disease. We are results driven, and enjoy a record of success in our laboratory studies. With the expertise in pharmacology, clinical neurology, computational chemistry, molecular modeling, synthetic organic chemistry and cellular and molecular biology.